Data as of Dec 06
| -0.02 / -0.74%|
The 2 analysts offering 12-month price forecasts for Echo Therapeutics Inc have a median target of 7.18, with a high estimate of 9.35 and a low estimate of 5.00. The median estimate represents a +167.72% increase from the last price of 2.68.
The current consensus among 2 polled investment analysts is to Outperform stock in Echo Therapeutics Inc. This rating has held steady since November, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.